Atlas Venture Opportunity Fund Ii, L.P. Dyne Therapeutics, Inc. (DYN) insider trading activity

Atlas Venture Opportunity Fund Ii, L.P. is > 10% Shareholder of Dyne Therapeutics, Inc.. Currently has a direct ownership of 934,581 shares of DYN, which is worth approximately $22.9 Million. The most recent transaction as insider was on Dec 12, 2022, when has been sold 934,581 shares (Common Stock) at a price of $10.7 per share, resulting in proceeds of $10,000,016. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 935K

0% 3M change

0% 12M change

Total Value Held $22.9 Million

Atlas Venture Opportunity Fund II, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 12 2022	BUY Open market or private purchase	$10,000,016 $10.7 p/Share	934,581 Added 50.0%	934,581 Common Stock

Also insider at

DAWN

Day One Biopharmaceuticals, Inc. Healthcare

> 10% Shareholder

FREQ

Frequency Therapeutics, Inc. Healthcare

AVO